These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35340932)

  • 61. Glycoconjugation of Betulin Derivatives Using Copper-Catalyzed 1,3-Dipolar Azido-Alkyne Cycloaddition Reaction and a Preliminary Assay of Cytotoxicity of the Obtained Compounds.
    Grymel M; Pastuch-Gawołek G; Lalik A; Zawojak M; Boczek S; Krawczyk M; Erfurt K
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm.
    Wei MX; Tamiya T; Rhee RJ; Breakefield XO; Chiocca EA
    Clin Cancer Res; 1995 Oct; 1(10):1171-7. PubMed ID: 9815909
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue.
    Chen KC; Schmuck K; Tietze LF; Roffler SR
    Mol Pharm; 2013 May; 10(5):1773-82. PubMed ID: 23448264
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endogenous H
    Bobba KN; Saranya G; Sujai PT; Joseph MM; Velusamy N; Podder A; Maiti KK; Bhuniya S
    ACS Appl Bio Mater; 2019 Mar; 2(3):1322-1330. PubMed ID: 35021379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects.
    Yang Z; Li H; Zhang W; Zhang M; He J; Yu Z; Sun X; Ni P
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
    Yang S; Shim MK; Kim WJ; Choi J; Nam GH; Kim J; Kim J; Moon Y; Kim HY; Park J; Park Y; Kim IS; Ryu JH; Kim K
    Biomaterials; 2021 May; 272():120791. PubMed ID: 33831739
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective activation of anthracycline prodrugs for use in conjunction with ADEPT.
    HariKrishna D; Rao AR; Krishna DR
    Drug News Perspect; 2003 Jun; 16(5):309-18. PubMed ID: 12942162
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthetic modification of hydroxychavicol by Mannich reaction and alkyne-azide cycloaddition derivatives depicting cytotoxic potential.
    Kumar S; Pathania AS; Satti NK; Dutt P; Sharma N; Mallik FA; Ali A
    Eur J Med Chem; 2015 Mar; 92():236-45. PubMed ID: 25559204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy.
    Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y
    J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors.
    Ikeda Y; Hisano H; Nishikawa Y; Nagasaki Y
    Mol Pharm; 2016 Jul; 13(7):2283-9. PubMed ID: 27187083
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dependence of aldehyde dehydrogenase-mediated oxazaphosphorine resistance on soluble thiols: importance of thiol interactions with the secondary metabolite acrolein.
    Bunting KD; Townsend AJ
    Biochem Pharmacol; 1998 Jul; 56(1):31-9. PubMed ID: 9698086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. One-Pot Synthesis of pH/Redox Responsive Polymeric Prodrug and Fabrication of Shell Cross-Linked Prodrug Micelles for Antitumor Drug Transportation.
    Li L; Li D; Zhang M; He J; Liu J; Ni P
    Bioconjug Chem; 2018 Aug; 29(8):2806-2817. PubMed ID: 30005157
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of acrolein in comparison to its prodrug cyclophosphamide on human primary endothelial cells in vitro.
    Lau S; Rangarajan R; Philidet C; Krüger-Genge A; Braune S; Kammerer S; Küpper JH; Lendlein A; Jung F
    Toxicol In Vitro; 2020 Feb; 62():104685. PubMed ID: 31634544
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy.
    Liang Y; Huang W; Zeng D; Huang X; Chan L; Mei C; Feng P; Tan CH; Chen T
    Drug Deliv; 2018 Nov; 25(1):1350-1361. PubMed ID: 29869567
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancer.
    Fang T; Ye Z; Chen X; Wang Y; Wan J; Wang H
    Int J Pharm; 2021 Apr; 599():120399. PubMed ID: 33647408
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.
    Nishikubo K; Ohgaki R; Liu X; Okanishi H; Xu M; Endou H; Kanai Y
    Cancer Cell Int; 2023 Jun; 23(1):116. PubMed ID: 37322479
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
    Hou W; Fan Q; Su L; Xu H
    Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prodrug Activation by Gold Artificial Metalloenzyme-Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination.
    Chang TC; Vong K; Yamamoto T; Tanaka K
    Angew Chem Int Ed Engl; 2021 May; 60(22):12446-12454. PubMed ID: 33719151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.